scholarly journals Symptoms Following Discontinuation of Tyrosine Kinase Inhibitor (TKI) Therapy After Achieving an Adequate Response in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

2018 ◽  
Vol 18 ◽  
pp. S221-S222
Author(s):  
Ellen K. Ritchie ◽  
Islam Sadek ◽  
Irina Pivneva ◽  
Annie Guerin ◽  
Dominick Latremouille-Viau ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Myeloid Leukemia ◽  
Kinase Inhibitor ◽  
Chronic Phase ◽  
Adequate Response

Comparing the efficacy of generic Imatinib formulations with the original Imatinib as the frontline tyrosine kinase inhibitor in chronic phase chronic myeloid leukemia.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e18024-e18024 ◽  
Author(s):  
Fatih Demirkan ◽  
Omur Gokmen Gokmen Sevindik ◽  
Aysegul Karaman ◽  
Inci Alacacioglu ◽  
Serife Medeni Solmaz ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Myeloid Leukemia ◽  
Kinase Inhibitor ◽  
Chronic Phase
Sign in / Sign up

Export Citation Format

Share Document